Michael Baker

Michael Baker

Company: Arovella Therapeutics

Job title: CEO and MD


Minimizing Alloreactivity through Innovative Stealth Approaches 2:00 pm

Exploring strategies for evading detection and recognition by the immune system Potency vs stealth: evaluating prioritization of therapy characteristics dependent on disease type and severityRead more

day: Clinical Track Day Two PM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.